5 results on '"Pae M"'
Search Results
2. Luteolin inhibits NLRP3 inflammasome activation via blocking ASC oligomerization.
- Author
-
Lee MN, Lee Y, Wu D, and Pae M
- Subjects
- Animals, Cell Line, Cells, Cultured, Female, Inflammation drug therapy, Inflammation metabolism, Macrophages drug effects, Macrophages metabolism, Mice, Inbred C57BL, Mice, Anti-Inflammatory Agents pharmacology, CARD Signaling Adaptor Proteins metabolism, Inflammasomes metabolism, Luteolin pharmacology, NLR Family, Pyrin Domain-Containing 3 Protein metabolism
- Abstract
The NLRP3 inflammasome is a caspase-1 containing multi-protein complex that controls the release of IL-1β and plays important roles in the innate immune response. Since NLRP3 inflammasome is implicated in the pathogenesis of a variety of diseases, it has become an increasingly interested target in developing therapies for multiple diseases. We reported the current study to determine how luteolin, a natural phenolic compound found in many vegetables and medicinal herbs, would modulate NLRP3 inflammasome in both the in vivo and in vitro settings. First, we found that a high-fat diet upregulated mRNA expression of NLRP3 inflammasome components Asc and Casp1 in adipose tissue of ovariectomized mice, which were greatly reduced by dietary supplementation with luteolin. Of note, Asc and Casp1 expression in adipose tissue correlated with mRNA levels of Adgre1 encoding F4/80, an established marker for mature macrophages. We also demonstrated that luteolin inhibited NLRP3 inflammasome-derived caspase-1 activation and IL-1β secretion in J774A.1 macrophages upon diverse stimuli including ATP, nigericin, or silica crystals. Luteolin inhibited the activation step of NLRP3 inflammasome by interfering with ASC oligomerization. Taken together, these findings suggest that luteolin supplementation may suppress NLRP3 induction and activation process and thus potentially would be protective against NLRP3-mediated inflammatory diseases., (Copyright © 2021. Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
3. Luteolin reduces adipose tissue macrophage inflammation and insulin resistance in postmenopausal obese mice.
- Author
-
Baek Y, Lee MN, Wu D, and Pae M
- Subjects
- Adipose Tissue pathology, Adiposity, Animals, Cell Polarity drug effects, Diet, High-Fat adverse effects, Dietary Supplements, Female, Gene Expression Regulation drug effects, Insulin Resistance, Lipopolysaccharides pharmacology, Macrophages pathology, Mice, Mice, Inbred C57BL, Obesity pathology, Panniculitis genetics, Panniculitis pathology, Postmenopause, RAW 264.7 Cells, Adipose Tissue drug effects, Luteolin pharmacology, Macrophages drug effects, Obesity complications, Panniculitis diet therapy
- Abstract
Previously, we showed that loss of ovarian function in mice fed high-fat diet exacerbated insulin resistance and adipose tissue inflammation. In the current study, we tested whether consumption of luteolin, an anti-inflammatory flavonoid, could mitigate adipose tissue inflammation and insulin resistance in obese ovariectomized mice. Nine-week-old ovariectomized C57BL/6 mice were fed a low-fat diet, high-fat diet (HFD) or HFD supplemented with 0.005% luteolin (HFD+L) for 16 weeks. Results showed no difference in body weight or fat mass between mice fed HFD+L and those fed HFD. However, luteolin supplementation resulted in lower CD11c
+ macrophages in gonadal adipose tissue, as well as a trend toward lower macrophage infiltration. Luteolin supplementation also significantly lowered mRNA expression of inflammatory and M1 markers MCP-1, CD11c, TNF-α and IL-6, while maintaining expression of M2 marker MGL1. Consistent with this, the in vitro luteolin treatment, with or without the presence of estrogen, inhibited lipopolysaccharide-induced polarization of RAW 264.7 cells toward M1 phenotype. We further found that luteolin supplementation protected mice from insulin resistance induced by HFD consumption; this improved insulin resistance was correlated with reductions in CD11c+ adipose tissue macrophages. Taken together, these findings indicate that dietary luteolin supplementation attenuates adipose tissue inflammation and insulin resistance found in mice with loss of ovarian function coupled with an HFD intake, and this effect may be partly mediated through suppressing M1-like polarization of macrophages in adipose tissue. These results have clinical implication in implementing dietary intervention for prevention of metabolic syndrome associated with postmenopause and obesity., (Copyright © 2019 Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
4. Loss of ovarian function in association with a high-fat diet promotes insulin resistance and disturbs adipose tissue immune homeostasis.
- Author
-
Pae M, Baek Y, Lee S, and Wu D
- Subjects
- Adipose Tissue drug effects, Adipose Tissue pathology, Animals, B-Lymphocytes drug effects, Body Weight drug effects, Female, Gene Expression Regulation drug effects, Glucose metabolism, Homeostasis drug effects, Homeostasis immunology, Killer Cells, Natural drug effects, Macrophages immunology, Macrophages metabolism, Mice, Inbred C57BL, Ovariectomy, Ovary drug effects, Panniculitis etiology, Panniculitis genetics, T-Lymphocytes, Regulatory drug effects, Adipose Tissue immunology, Diet, High-Fat adverse effects, Insulin Resistance physiology, Ovary physiopathology
- Abstract
Loss of ovarian function, as occurs in menopause or after ovariectomy (OVX), is associated with insulin resistance. Adipose tissue inflammation is suggested to be a key component of obesity-induced insulin resistance in male rodents. However, little is known about the effect of OVX and diet on insulin resistance in association with immune homeostasis. Thus, we conducted this study to determine how high-fat diet (HFD) and OVX, alone or in combination, impacted adipose tissue inflammation and insulin resistance. Nine-week-old sham and OVX-treated C57Bl/6 mice were fed low-fat diet (LFD) or HFD (60%) up to 16 weeks. Glucose metabolism was assessed, and adipose tissue and spleen were characterized for tissue inflammation and immune cell populations. First, we found that HFD induced glucose intolerance in both OVX mice and, to a lesser extent, sham mice. OVX mice fed LFD showed no difference in glucose intolerance compared to sham mice. Additionally, OVX mice only when exposed to HFD displayed a proinflammatory profile in adipose tissue: increased macrophages together with dominant M1-like phenotype and also increased T cells, B cells and NK cells compared to those with intact ovarian function. Together, our findings indicate that loss of ovarian function coupled with an HFD intake promotes insulin resistance and adipose tissue inflammation by disturbing adipose tissue immune homeostasis. These findings have a clinical implication in the dietary guidance for menopausal women., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
5. Differential effect of dietary vitamin D supplementation on natural killer cell activity in lean and obese mice.
- Author
-
Lee GY, Park CY, Cha KS, Lee SE, Pae M, and Han SN
- Subjects
- Adipose Tissue drug effects, Animals, Body Weight drug effects, Cytokines metabolism, Diet, High-Fat adverse effects, Dietary Supplements, Gene Expression Regulation drug effects, Interferon-gamma metabolism, Killer Cells, Natural physiology, Leptin blood, Lysosomal Membrane Proteins metabolism, Male, Mice, Inbred C57BL, NK Cell Lectin-Like Receptor Subfamily K metabolism, Obesity pathology, Spleen cytology, Vitamin D genetics, Vitamin D metabolism, Killer Cells, Natural drug effects, Obesity immunology, Vitamin D pharmacology
- Abstract
Vitamin D has an immunoregulatory effect on both innate and adaptive immunity. Contradictory results regarding vitamin D and natural killer (NK) cell functions have been reported with in vitro studies, but little is known about this in vivo. We investigated whether vitamin D levels (50, 1000 or 10,000 IU/kg of diet: DD, DC or DS) affect NK cell functions in mice fed a control or high-fat diet (10% or 45% kcal fat: CD or HFD) for 12 weeks. The splenic NK cell activity was significantly higher in the CD-DS group than the HFD-DS group, and the CD-DS group showed significantly higher NK cell activity compared with the CD-DD and CD-DC groups. However, no difference in NK cell activity was observed among the HFD groups fed different levels of vitamin D. The splenic population of NK cells was significantly higher in the CD-DS group than the HFD-DS group. There was no difference in the intracellular expression of IFN-γ and the surface expression of NKG2D and CD107a in NK cells by both dietary fat and vitamin D content. The splenic mRNA expression of Ifng and Ccl5 was significantly lower in the HFD groups compared with the CD groups, but there was no difference in the mRNA levels of Vdup1 and Vdr among the groups. Taken together, these results suggest that dietary vitamin D supplementation can modulate innate immunity by increasing NK activity in control mice but not in obese mice. This effect might be mediated through alternation of the splenic NK cell population., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.